Heart surgery hope for patients with dangerously low platelets

NCT ID NCT07278661

Recruiting now Disease control Sponsor: Nantes University Hospital Source: ClinicalTrials.gov ↗

First seen Jan 04, 2026 · Last updated May 14, 2026 · Updated 18 times

Summary

This study tests a drug called romiplostim given before heart surgery to people with low platelet counts. The goal is to see if it can raise platelet levels enough to make surgery safer and reduce the need for blood transfusions. About 136 adults will take part, and half will get the drug while the other half gets a placebo.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

CHU d'Angers
NOT_YET_RECRUITING

Angers, France

Contact Email: •••••@•••••
CHU de Bordeaux
NOT_YET_RECRUITING

Bordeaux, France

Contact Email: •••••@•••••
CHU de Brest
NOT_YET_RECRUITING

Brest, France

Contact Email: •••••@•••••
CHU de Dijon
NOT_YET_RECRUITING

Dijon, France

Contact Email: •••••@•••••
CHU de Nantes
RECRUITING

Nantes, France

Contact Email: •••••@•••••
CHU de Rennes
NOT_YET_RECRUITING

Rennes, France

Contact Email: •••••@•••••
CHU de Strasbourg
NOT_YET_RECRUITING

Strasbourg, France

Contact Email: •••••@•••••
Hôpital Bichat (AP-HP)
NOT_YET_RECRUITING

Paris, France

Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

CHIRURGICAL INTERVENTION THROMBOCYTOPAENIA